Your browser doesn't support javascript.
loading
Crystal forms in pharmaceutical applications: olanzapine, a gift to crystal chemistry that keeps on giving.
Reutzel-Edens, Susan M; Bhardwaj, Rajni M.
Afiliação
  • Reutzel-Edens SM; Synthetic Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Bhardwaj RM; Synthetic Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN 46285, USA.
IUCrJ ; 7(Pt 6): 955-964, 2020 Nov 01.
Article em En | MEDLINE | ID: mdl-33209310
ABSTRACT
This contribution reviews the efforts of many scientists around the world to discover and structurally characterize olanzapine crystal forms, clearing up inconsistencies in the scientific and patent literature and highlighting the challenges in identifying new forms amidst 60+ known polymorphs and solvates. Owing to its remarkable solid-state chemistry, olanzapine has emerged over the last three decades as a popular tool compound for developing new experimental and computational methods for enhanced molecular level understanding of solid-state structure, form diversity and crystallization outcomes. This article highlights the role of olanzapine in advancing the fundamental understanding of crystal forms, interactions within crystal structures, and growth units in molecular crystallization, as well as influencing the way in which drugs are developed today.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: IUCrJ Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: IUCrJ Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos